Hunig; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hunig; Thomas.The latest application filed is for "device for welding components by means of ultrasound".

Company Profile

0.11.16

Hunig; Thomas - Grosswallstadt DE
Hunig; Thomas - Wuerzburg N/A DE
Hunig; Thomas - Wurzberg DE
Hunig; Thomas - Wurzburg DE
Hunig; Thomas - Winterhausen DE
Hunig; Thomas - Wintehausen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Device and method for crimping connection elements, and crimping connection Grant 11,374,372 - Schneider , et al. June 28, 2	2022-06-28
Device for welding components by means of ultrasound Grant 11,247,294 - Solenthaler , et al. February 15, 2	2022-02-15
Device For Welding Components By Means Of Ultrasound App 20200171598 - SOLENTHALER; Peter ; et al.	2020-06-04
Sonotrode, device and method for producing a join Grant 10,554,004 - Bohm , et al. Fe	2020-02-04
Device for welding components by means of ultrasound Grant 10,532,424 - Solenthaler , et al. Ja	2020-01-14
Device And Method For Crimping Connection Elements, And Crimping Connection App 20190157825 - SCHNEIDER; Axel ; et al.	2019-05-23
Sonotrode, Device And Method For Producing A Join App 20180219345 - BOHM; Markus ; et al.	2018-08-02
Device For Welding Components By Means Of Ultrasound App 20180185956 - SOLENTHALER; Peter ; et al.	2018-07-05
Peptide or protein comprising a C'-D loop of the CD28 receptor family Grant 8,586,386 - Hunig , et al. November 19, 2	2013-11-19
Use Of A Cd28 Binding Substance For Making A Pharmaceutical Composition App 20130266577 - Hunig; Thomas	2013-10-10
Use of a CD28 binding substance for making a pharmaceutical composition Grant 8,389,016 - Hunig March 5, 2	2013-03-05
Human CD28 specific monoclonal antibodies for antigen-nonspecific activation of T-lymphocytes Grant 8,334,102 - Hunig December 18, 2	2012-12-18
Method for Preclinical Testing of Immunomodulatory Drugs App 20110082091 - Hunig; Thomas	2011-04-07
Peptide Or Protein Comprising A C'-d Loop Of The Cd28 Receptor Family App 20110052587 - Hunig; Thomas ; et al.	2011-03-03
Human Cd28 Specific Monoclonal Antibodies For Antigen-nonspecific Activation Of T-lymphocytes App 20110009602 - HUNIG; Thomas	2011-01-13
Microparticle with cd28-specific monoclonal antibodies Grant 7,868,143 - Hunig January 11, 2	2011-01-11
Use Of A Cd28 Binding Substance For Making A Pharmaceutical Composition App 20090246204 - Hunig; Thomas	2009-10-01
Use of a CD28 binding substance for making a pharmaceutical composition App 20070134240 - Hunig; Thomas	2007-06-14
Peptide or protein containing a C'-D loop of the CD28 receptor family App 20070031407 - Hunig; Thomas ; et al.	2007-02-08
Microparticle with cd28-specific monoclonal antibodies App 20060121021 - Hunig; Thomas	2006-06-08
Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes App 20060039909 - Hunig; Thomas	2006-02-23
Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes Grant 6,987,171 - Hunig January 17, 2	2006-01-17
Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28 App 20040247594 - Hunig, Thomas ; et al.	2004-12-09
Use of a CD28 binding substance for making a pharmaceutical composition App 20040092718 - Hunig, Thomas	2004-05-13
Peptide or protein containing a C '-D loop of the CD28 receptor family App 20030166860 - Hunig, Thomas ; et al.	2003-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.